Evidence map›Paper›PMID 42490371›Full record

ArticleJournal of the American Chemical Society2026

Formal Markovnikov Hydroazolation of Alkenes via Reductive Activation of Alkylthianthrenium Salts.

Adrian D Matthews, John R Lorenz, Zachary K Wickens

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adrian D MatthewsDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin53706, United States.ORCID 0000-0003-4320-4057
John R LorenzDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin53706, United States.
Zachary K WickensDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin53706, United States.ORCID 0000-0002-5733-5288

Funding

electrochemical dication pool: a new strategy to couple alkenes and abundant nucleophilesR01GM149674 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Zachary Kimble Wickens · 2023 to 2026
$1.2M
Laser-Enhanced NMR Instrumentation for Chemical and Biochemical ResearchS10OD012245 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI CAVAGNERO, SILVIA · 2013 to 2013
$1.0M
QExactive (Orbitrap) mass spectrometerS10OD020022 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI VESTLING, MARTHA M · 2015 to 2015
$483k
National Institutes of Health (NIH) 1S10OD020022-1National Institutes of Health (NIH) R01 GM14967401National Institutes of Health (NIH) S10OD012245National Science Foundation Graduate Research Fellowship Program 2137424National Science Foundation (NSF) CHE-1048642NIGMS NIH HHS R01 GM149674NIH HHS S10 OD012245NIH HHS S10 OD020022
6 · The paper itself

Abstract

Herein, we introduce a new synthetic protocol for azole alkylation. Our strategy first engages azoles using alkenylthianthrenium electrophiles to provide 1,2-azolothianthrenium salts, then selectively excises the sulfonium moiety via single electron transfer (SET). Given that alkenylthianthrenium salts can be readily accessed from alkenes, the net azole addition-hydrogenolysis sequence unlocks a versatile approach to formal Markovnikov alkene hydroazolation. Moreover, the key radical intermediate formed after reduction can be engaged in reactions beyond hydrogen atom transfer (HAT), providing access to carboazolation products that would be otherwise prohibitively difficult to prepare. Mechanistic studies into the reduction of the alkylthianthrenium electrophile implicate an unusual silyl radical attack on DMF that generates a strong SET reductant in situ under otherwise exceedingly mild conditions. Overall, this work introduces new approaches to transform alkylsulfonium building blocks and immediately expands the range of N-alkyl azole molecules that can be readily prepared and studied.

Identifiers

PMID42490371
PMCPMC13449957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.